In a study published in Cell, Host & Microbe earlier this year, the largest longitudinal study of the microbiome to date, researchers saw dramatic shifts in the gut bacteria of children who went on to develop type 1 diabetes. The study could have important implications for identifying the disease at a very early stage, delaying […]
This list below is seven behaviors that we can control. With practice, we can stop them altogether and live a much happier life. Being aware of these behaviors in ourselves is the first step to creating a happier life.
Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), the first and only concentrated mealtime insulin analog in the U.S., is now available in pharmacies. Humalog U-200 KwikPen is a prefilled pen containing a concentrated formulation of Lilly’s rapid-acting insulin Humalog®
Individuals who are diagnosed with type 1 diabetes in their later childhood are more likely to have weaker brain connectivity in middle age compared with people diagnosed at a younger age, according to a new study.
Diabetes can damage a number of organs, from the eyes to the kidneys and the heart. Now there’s fresh evidence that unchecked blood sugar can affect the brain as well, which may lead to drops in cognitive functions
Locemia Solutions is developing a nasal glucagon delivery system that doesn’t require any mixing or needle jabs. The goal is to expand the field of people who might be able to help in a crisis, says Locemia CEO Claude Piché.
Dr. Nitesh D. Kuhadiya, MPH, of the State University of New York at Buffalo, and colleagues, conducted a retrospective analysis of 10 patients on continuous glucose monitoring treated with insulin, Victoza (liraglutide) and Farxiga (dapagliflozin).
The proposed five-year study is designed to investigate whether repeated injections of the tuberculosis vaccine bacille Calmette-Guerin (or BCG vaccine) can quiet the immune system attack that causes type 1 diabetes and improve blood sugar levels in people with long-standing diabetes.
Although people with diabetes are more likely to be diagnosed with kidney disease, you can slow its progress significantly if you catch it early and get treated. Here are three ways you can lower your risk of developing kidney disease.
Diabetes researchers are hoping that an almost century-old vaccine for preventing tuberculosis may also reverse type 1 diabetes. The FDA has approved a mid-stage trial to test the vaccine, called bacillus Calmette-Guerin (BCG), in 150 adults with advanced cases of the disease.
People with type 1 diabetes have to be cautious when they exercise or do any kind of physical activity to avoid setting their blood glucose levels out of sorts.
The FDA recently announced the approval of the Gastric Emptying Breath Test (GEBT) as a diagnostic tool for gastroparesis – this condition is, though not as well known, a common complication of diabetes.
Sometimes, promising Type 1 diabetes treatments are developed from treatments for other conditions. If you have Type 1 diabetes, there’s good reason to be interested in what’s happening with the BCG vaccine, a treatment used to curb the spread of tuberculosis.
In their annual report, the Diabetes Research Institute Foundation recently highlighted their Top 6 research breakthroughs in 2014.
Doctors at Joslin Diabetes Center think America’s emerging healthcare system will greatly benefit those with complex, chronic disorders like type 1 diabetes.
Women with type 1 diabetes face a greater risk of dying from a range of diseases compared with men with the same condition, research suggests.
In some young children who develop type 1 diabetes, a change in normal stomach bacteria can precede the disease by a year, a small study has found. The findings, published Feb. 5 in the journal Cell, Host & Microbe, are based on just 33 children at increased genetic risk of type 1 diabetes . And […]
The technique involves the examination of unmyelinated nerve fibers at high magnification using a laser-scanning corneal confocal microscope to image the subbasal nerve plexus of the patient’s cornea. Increased severity of diabetic peripheral neuropathy is associated with reduced corneal-nerve fiber length and corneal sensitivity.
Researchers studied the effectiveness of new insulin glargine 300 U/mL (Gla-300) vs insulin glargine 100 U/mL (Gla-100) in patients with type 1 diabetes. In two small double-blind, randomized, crossover studies, insulin glargine concentration and glucose infusion rates were more constant and prolonged with Gla-300.
Despite major advances in the treatment of type 1 diabetes over the past 30 years, type 1 men are living approximately 11 fewer years than their non-diabetic peers. For women, the years lost is even higher at 13.